|
TTD
Drug ID:
DAP000663
Drug
Information |
Name | Sirolimus | Synonyms | CID5924240; Perceiva; heptadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy; 3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone; nchembio883-comp3; SILA 9268A; DivK1c_006936; KBioGR_000410; Rapamycin Immunosuppressant Drug; AY-22989; UNM-0000358684; MLS000028373; (6H,31H)-pentone, 4,9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-; Sirolimus [USAN:BAN:INN]; (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-; NCI60_001851; Sirolimus, Rapamune,Rapamycin; CID5497196; CID5374464; DB00877; Bio2_000855; KBio1_001880; nchembio.79-comp1; Bio2_000375; CID6610346; CID9854379; D00753; Rapamune; CID10795871; Bio1_000782; KBio3_000780; Rapamycin (TN); 1pbk; SMR000058564; C07909; (3-(4-hydroxy-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-; CID6711160; CID9854380; MolMap_000043; KBio2_002978; Sirolimus (USAN/INN); WY-090217; SpecPlus_000840; CID5358081; CHEMBL413; LS-143290; CCRIS 9024; Rapamune (TN); NSC 226080; CID9962928; DE-109; R0395_SIAL; CHEBI:100923; Sirolimus (RAPAMUNE); 1fkb; Sirolimus; MS-R001; CBiol_002007; CID6610270; nchembio762-comp1; BiomolKI2_000084; KBio2_000410; HSDB 7284; CID5284616; 53123-88-9; AC1L9ZMV; NCIMech_000355; CID9833581; 9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-; rapamycin; Bio1_000293; CID11959112; CID5040; KBio2_005546; CID5460439; CID10213190; NCGC00021305-05; 19E,21R*,23R*,26S*,27S*,34aR*))-; 23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29; CID313006; 23,27-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine; FT-0082351; RPM; 23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine; RAP; QTL1_000069; Ambotz53123-88-9; Rapamycin C-7, analog 4; (-)-Rapamycin; SIIA 9268A; UNII-W36ZG6FT64; R0395_SIGMA; C51H79NO13; BIDD:PXR0165; S1039_Selleck; nchembio.100-comp4; CID9962926; Bio1_001271; RAPA; KBioSS_000410; nchembio.2007.42-comp2; LMPK06000003; CHEBI:9168; CID6436030; SMP1_000255; Rapamycin from Streptomyces hygroscopicus; AC1L1JH9; AC-722; A422989, NSC226080; AY 22989; HMS2089A21; CID11949238; NSC226080; CID478951; Rapammune; Antibiotic AY 22989; LCP-Siro; MolPort-003-959-433; Wy 090217; AC1L7MJ9; KBio3_000779; CID6713081 | Trade Name | Rapamune | Company | Wyeth | Indication | Dutch Elm disease | Phase I/II [1] | Organ rejection | Approved [1] | Structure |
Click to save drug structure in 3D MOL format
Click to save drug structure in 2D MOL format | Therapeutic Class | Immunosuppressive Agents | CAS Number | CAS 53123-88-9 | Formular | C51H79NO13 | PubChem Compound ID | CID 6436030. | PubChem Substance ID | SID 207443. | ChEBI | 9168; | SuperDrug ATC ID | L04AA10; | SuperDrug CAS ID | 053123889; | Target | Serine/threonine-protein kinase mTOR |  | Inhibitor | [2] | Ref 1 | Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. Epub 2007 Feb 20. To Reference | Ref 2 | Nat Rev Drug Discov. 2003 Jan;2(1):38-51.Knockouts model the 100 best-selling drugs--will they model the next 100? To Reference |
Welcome
to sign our Guestbook.
If you
find any error in data or bug in web service, please kindly report it
to Dr.
Zhu.
Dr.
Chen Yuzong
Deputy Director of Center
for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore
All rights reserved.
|
|